The UK has become the first country in Europe to authorise the daily weight loss pill Foundayo, which is designed for those with a BMI of 30 or above or specific weight-related conditions. As an alternative to injectable treatments, the drug also helps manage blood sugar levels for patients with type 2 diabetes. Pharmacists are advising patients to ensure they only access the medication through licensed channels to avoid counterfeit versions.